ESIC circular 611/U-16/27/01/24/DrugTesting/ESICH-RDR · 02 Jun 2026
Official record
Open source pageSummary
Check the official recordESIC Hospital Rudrapur informs the Deputy Medical Commissioner about drug testing samples sent to PMBI willingness firms for April 2026. The hospital submitted a sample of Ondansetron Injection 2 mg/ml, batch number AV6076, manufactured by Alpa Laboratories Limited. The hospital collected the sample on 25 May 2026. ITL Labs Pvt. Ltd. performs the testing. The laboratory report for this item remains pending. This communication serves as formal intimation to the ESIC Headquarters for necessary action.
What you must do
Key dates
कमचार राय बीमा िनगम (म और रोजगार मंालय, भारत सरकार) EMPLOYEE STATE INSURANCE CORPOPRATION (Ministry of labor and Employment, Govt. of India)
क.रा. बी. िन अपताल, पुिलस लाइन के पास, पुर , उ#राखंड /ESIC Hospital, Near Police Line, RUDRAPUR, Uttarakhand Email: ms- rudrapur.uchal@esic.nic.in website:www.esic.nic.in/www.esic.in
| ESI Institution Name | Drug/Item Name | Batch No. | Mfg. By | Date of Mfg. (DOM) | Date of Expiry (DOE) | RC drugs/Jan-Aushidi Drugs/CPSE Drugs/Others | If RC drugs (RC No.) (i) Item No. (ii) | Date of Sampling | Name of Testing Laboratories | Reports |
|---|---|---|---|---|---|---|---|---|---|---|
| ESIC Hospital RUDRAPUR | 1) Ondansetron Inj. 2 mg/ml-4ml | AV6076 | Alpa Laboratories Limited | 31-03-2026 | 29-02-2028 | RC Drug | 159 388 | 25-05-2026 | ITL Labs Pvt. Ltd. | Awaited |
To Date 02-06-2026 The Deputy Medical Commissioner DMC ( RC) ESIC HQ , New Delhi
Subject- Drug testing Samples for the Month April-2026 to PMBl Willingness Firms Reference-e file: 611/U-16/27/01/24/DrugTesting/ESICH-RDR (580950) testing of drugs correspondence file With reference to the above subject, kindly find the Enclosures regarding Drug testing Samples for the Month April-2026 to PMBI Willingness Firms. This is for your kind intimation and further necessary action.
This has the approval of the Medical Superintendent in even e file
Store In charge
611/U-16/27/01/24/DrugTesting/ESICH-RDR I/3956871/2026
611/U-16/27/01/24/DrugTesting/ESICH-RDR I/3956871/2026
Who is affected